The calcium‐sensing receptor: A novel target for treatment and prophylaxis of neratinib‐induced diarrhea

Abstract Diarrhea is one of the most commonly reported adverse effect of hemotherapy and targeted cancer therapies, such as tyrosine kinase inhibitors (TKI), which often significantly impact patient quality of life, morbidity, and mortality. Neratinib is an oral, irreversible pan‐HER tyrosine kinase...

Full description

Saved in:
Bibliographic Details
Main Authors: Taras Lysyy (Author), Alshad S. Lalani (Author), Elizabeth A. Olek (Author), Irmina Diala (Author), John P. Geibel (Author)
Format: Book
Published: Wiley, 2019-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available